Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02735551 · ClinicalTrials.gov registry record · Phase 4
LARC Forward Contraceptive Counseling at MHCC
A Phase 4 study, sponsored by Oregon Health and Science University.
- Terminated
- Registry status
- Phase 4
- Development phase
- 3
- Enrollment target
NCT02735551 is a Phase 4 study that was terminated before completion, run by Oregon Health and Science University. The registered enrollment target is 3 participants.
The verdict
NCT02735551, a Phase 4 study, was terminated before completion, sponsored by Oregon Health and Science University.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 3 participants
- Enrollment target
Study Summary
This prospective randomized controlled study will evaluate if Long Acting Reversible Contraceptive (LARC) forward counseling in combination with same-day LARC placement increases overall LARC uptake within a community college population compared to LARC forward counseling and referral to a secondary clinic for LARC placement. The study will be conducted at Mount Hood Community College (MHCC) in Oregon. Participants will be enrolled into three groups. All groups will receive the same standardized contraceptive counseling ("LARC forward counseling") and participants will be able to choose between a LARC method and short-acting method of birth control.
Interventions
- DRUG Long Acting Reversible Contraception (LARC)
- OTHER Referral for Long Acting Reversible Contraception (LARC)
- OTHER Prescription for Short-Acting Hormonal Contraception
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2016-04 |
| Est. Completion | 2017-03-31 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02735551
The ClinicalTrials.gov registry entry for NCT02735551 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Oregon Health and Science University, which has 546 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Long Acting Reversible Contraception (LARC) is the first listed.
NCT02735551 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02735551 about?
NCT02735551 is a clinical study titled "LARC Forward Contraceptive Counseling at MHCC". This prospective randomized controlled study will evaluate if Long Acting Reversible Contraceptive (LARC) forward counseling in combination with same-day LARC placement increases overall LARC uptake within a community college population compared to LARC forward counseling and referral to a secondary...
What is the current status of trial NCT02735551?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 3 participants. The study started on 2016-04. Estimated completion is 2017-03-31.
What interventions are being tested in trial NCT02735551?
The interventions under investigation include: Long Acting Reversible Contraception (LARC) (DRUG), Referral for Long Acting Reversible Contraception (LARC) (OTHER), Prescription for Short-Acting Hormonal Contraception (OTHER).
Who is sponsoring clinical trial NCT02735551?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.